Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001641172-25-025094
Filing Date
2025-08-21
Accepted
2025-08-21 16:30:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 form424b3.htm 424B3 333703
2 GRAPHIC form424b3_001.jpg GRAPHIC 13860
  Complete submission text file 0001641172-25-025094.txt   354008
Mailing Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608
Business Address C/O MEITAR LAW OFFICES 16 ABBA HILLEL SILVER RD. RAMAT GAN L3 5250608 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

EIN.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-289703 | Film No.: 251241235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)